Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.
暂无分享,去创建一个
P C Prorok | W F Taylor | W. R. Taylor | P. Prorok | E. Bergstralh | D. Williams | R. Fagerstrom | P. Marcus | R. Fontana | W. Taylor | P M Marcus | E J Bergstralh | R M Fagerstrom | D E Williams | R Fontana | David E. Williams
[1] W F Taylor,et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. , 2015, The American review of respiratory disease.
[2] P. Prorok,et al. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification , 1999, Journal of medical screening.
[3] G. Friedman,et al. Screening in chronic disease , 2004, Cancer Causes & Control.
[4] T. Visakorpi,et al. Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis. , 1996, International journal of cancer.
[5] P. Prorok,et al. Concepts and problems in the evaluation of screening programs. , 1981, Journal of chronic diseases.
[6] B. Achinstein,et al. Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.
[7] D. Schoenfeld,et al. Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.
[8] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[9] T. Visakorpi,et al. Low biological aggressiveness of screen‐detected lung cancers may indicate over‐diagnosis , 1996 .
[10] T. Naruke,et al. Survival for clinical stage I lung cancer not surgically treated. Comparison between screen‐detected and symptom‐detected cases , 1992, Cancer.
[11] V. Ernster,et al. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. , 1997, Journal of the National Cancer Institute. Monographs.
[12] M Kimmel,et al. Screening for lung cancer: The Mayo lung project revisited , 1993, Cancer.
[13] J. Lawless. Statistical Models and Methods for Lifetime Data , 2002 .
[14] G. Rhoads. The Epidemiologic Necropsy , 1987 .
[15] P. Prorok,et al. Issues in the mortality analysis of randomized controlled trials of cancer screening. , 1994, Controlled clinical trials.
[16] E. Bergstralh,et al. Screening for lung cancer. A critique of the mayo lung project , 1991, Cancer.
[17] R. Fontana,et al. Screening for Lung Cancer: A Progress Report on the Mayo Lung Project , 1981 .
[18] C. Wells,et al. The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. , 1987, JAMA.
[19] O. Miettinen,et al. Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.
[20] Screening for lung cancer. , 2000, Chest surgery clinics of North America.
[21] L. Ayvazian. Lung Cancer: Current Status and Prospects for the Future , 1987 .
[22] J. Mandel,et al. Screening in Chronic Disease , 1985 .
[23] A. Morrison,et al. Basic issues in population screening for cancer. , 1980, Journal of the National Cancer Institute.
[24] D. Wolpaw. Early detection in lung cancer. Case finding and screening. , 1996, The Medical clinics of North America.
[25] P. Prorok. Epidemiologic Approach for Cancer Screening: Problems in Design and Analysis of Trials , 1992, The American journal of pediatric hematology/oncology.
[26] G. Bepler,et al. Screening for lung cancer. , 2000, The New England journal of medicine.
[27] D. Sugarbaker,et al. Screening for Lung Cancer: Another Look; A Different View , 1997 .
[28] S. Ciatto,et al. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] W F Taylor,et al. Lung cancer screening: the Mayo program. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.